OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,020.00
-120.00 (-1.68%)
Last updated: Oct 10, 2025, 12:33 PM KST

OPTUS Pharmaceutical Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
82,81281,90572,42658,65857,31660,827
Upgrade
Other Revenue
-0-0-0---
Upgrade
82,81281,90572,42658,65857,31660,827
Upgrade
Revenue Growth (YoY)
6.46%13.09%23.47%2.34%-5.77%0.64%
Upgrade
Cost of Revenue
36,70637,27731,07227,04124,82122,531
Upgrade
Gross Profit
46,10744,62841,35431,61732,49538,296
Upgrade
Selling, General & Admin
34,74332,84630,62324,13820,58921,588
Upgrade
Research & Development
1,6181,8831,3841,3431,110821.84
Upgrade
Other Operating Expenses
282.21260.69164.19184.49110.92107.83
Upgrade
Operating Expenses
37,80236,11933,16826,36822,02323,489
Upgrade
Operating Income
8,3048,5098,1875,24910,47214,808
Upgrade
Interest Expense
-82.25-97.24-124.4-85.89-8.88-17.61
Upgrade
Interest & Investment Income
1,9192,3732,2961,401846.431,137
Upgrade
Currency Exchange Gain (Loss)
188.9184.83.3312.17127.54-17.39
Upgrade
Other Non Operating Income (Expenses)
-577.36-469.6211.7921.69-36.76105.62
Upgrade
EBT Excluding Unusual Items
9,75210,40010,3746,59811,40016,015
Upgrade
Gain (Loss) on Sale of Investments
1,1581,2421,96773.39-2,505
Upgrade
Gain (Loss) on Sale of Assets
49.14441.87629.3878.2944.24-18.97
Upgrade
Asset Writedown
----721.2-964.98-
Upgrade
Pretax Income
10,95912,08412,9706,82810,47918,502
Upgrade
Income Tax Expense
1,4531,7762,2101,816587.884,097
Upgrade
Net Income
9,50610,30810,7605,0129,89214,405
Upgrade
Net Income to Common
9,50610,30810,7605,0129,89214,405
Upgrade
Net Income Growth
-7.23%-4.20%114.69%-49.33%-31.33%-1.31%
Upgrade
Shares Outstanding (Basic)
151515161616
Upgrade
Shares Outstanding (Diluted)
151515161616
Upgrade
Shares Change (YoY)
0.19%0.48%-4.18%-1.07%-0.62%-1.20%
Upgrade
EPS (Basic)
622.14674.99708.00316.00617.00893.00
Upgrade
EPS (Diluted)
622.14674.99708.00316.00617.00893.00
Upgrade
EPS Growth
-7.41%-4.66%124.05%-48.78%-30.91%-0.11%
Upgrade
Free Cash Flow
-13,590-2,9039,109-3,955-3,55711,603
Upgrade
Free Cash Flow Per Share
-889.39-190.11599.36-249.37-221.87719.32
Upgrade
Gross Margin
55.68%54.49%57.10%53.90%56.69%62.96%
Upgrade
Operating Margin
10.03%10.39%11.30%8.95%18.27%24.34%
Upgrade
Profit Margin
11.48%12.59%14.86%8.54%17.26%23.68%
Upgrade
Free Cash Flow Margin
-16.41%-3.55%12.58%-6.74%-6.21%19.08%
Upgrade
EBITDA
12,55912,48612,4248,71212,89517,392
Upgrade
EBITDA Margin
15.17%15.24%17.15%14.85%22.50%28.59%
Upgrade
D&A For EBITDA
4,2553,9774,2383,4632,4232,585
Upgrade
EBIT
8,3048,5098,1875,24910,47214,808
Upgrade
EBIT Margin
10.03%10.39%11.30%8.95%18.27%24.34%
Upgrade
Effective Tax Rate
13.26%14.69%17.04%26.60%5.61%22.14%
Upgrade
Advertising Expenses
-2,0321,515364.81100.3670.72
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.